Trial Profile
A PILOT STUDY TO ASSESS THE EFFICACY OF RITUXIMAB VERSUS COMBINATION OF RITUXIMAB AND INTRAVENOUS CYCLOPHOSPHAMIDE IN THE TREATMENT OF REFRACTORY PEMPHIGUS
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Mar 2024
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Rituximab (Primary)
- Indications Pemphigus
- Focus Therapeutic Use
- 29 Oct 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 12 Nov 2013 New trial record